;Where the structural formula (A), R1 is one of H+, Na+, K+ or NH4+. R2 is one of fumaric acid ester products. It has the general structural formula of the combination of salicylic acid and fumaric acid through esterification reaction. This category of compounds possesses good effects in treatment of neurodegenerative diseases."/>
公开/公告号US2021179533A1
专利类型
公开/公告日2021-06-17
原文格式PDF
申请/专利号US202017105948
申请日2020-11-27
分类号C07C69/60;
国家 US
入库时间 2022-08-24 19:24:20